1. Home
  2. HMC vs RMD Comparison

HMC vs RMD Comparison

Compare HMC & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Honda Motor Company Ltd.

HMC

Honda Motor Company Ltd.

HOLD

Current Price

$26.54

Market Cap

34.0B

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$207.97

Market Cap

29.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMC
RMD
Founded
1946
1989
Country
Japan
United States
Employees
215320
10600
Industry
Auto Manufacturing
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0B
29.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HMC
RMD
Price
$26.54
$207.97
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
N/A
$292.56
AVG Volume (30 Days)
1.8M
1.3M
Earning Date
05-13-2026
04-30-2026
Dividend Yield
4.45%
1.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.60
Revenue Next Year
$4.36
$7.41
P/E Ratio
$40.40
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$23.25
$198.61
52 Week High
$34.89
$293.81

Technical Indicators

Market Signals
Indicator
HMC
RMD
Relative Strength Index (RSI) 63.12 43.72
Support Level $23.74 $198.63
Resistance Level $26.66 $260.21
Average True Range (ATR) 0.40 4.85
MACD 0.26 1.26
Stochastic Oscillator 94.59 62.06

Price Performance

Historical Comparison
HMC
RMD

About HMC Honda Motor Company Ltd.

Incorporated in 1948, Honda Motor was originally a motorcycle manufacturer. Today, the firm makes automobiles, motorcycles, and power products such as boat engines, generators, and lawnmowers. Including joint ventures, Honda sold 3.4 million light vehicles and 22.1 million motorcycles in fiscal 2026, and consolidated sales were JPY 21.8 trillion. Automobiles constitute 64% of revenue and motorcycles 18%, with the rest split between power products and financial services. Honda also makes robots and private jets.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: